Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Stock Price, Quote & AI Analysis
Live MIRM stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Mirum Pharmaceuticals, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Mirum Pharmaceuticals, Inc. Common Stock (MIRM), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Mirum Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Mirum Pharmaceuticals, Inc. Common Stock Overview
Company information
Company Overview
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Mirum Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...